Epsilogen acquires TigaTx to expand pan-isotope cancer antibody pipeline
Under the deal, TigaTx will become a wholly owned subsidiary of Epsilogen.
Cancer
NICE green lights two blood cancer therapies for NHS use
World Cancer Day: WHO warns of rising cancer burden in Southeast Asia
People-focused cancer care demands policy support
FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi
J&J’s Lazcluze/Rybrevant combination obtains European approval to treat NSCLC
BeiGene’s Tevimbra approved in US for first-line gastric cancer treatment
